|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
FY2017
12 months to Dec 31, 2017
|
|
|---|---|---|---|
| Cash flows from operating activities: | |||
| Net income | |||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Provision for loan losses | |||
| Depreciation | |||
| Gain on sale of premises and equipment | |||
| Net accretion of loan portfolio discount and deposit premium | |||
| Net amortization on securities available for sale | |||
| (Gain) loss on sales and impairments of foreclosed assets | |||
| Gain on sale of securities | |||
| Loss on sale of available for sale securities | |||
| Increase in cash surrender value of life insurance | |||
| Accretion of discount on FHLB advances | |||
| ESOP compensation | |||
| Stock based compensation | |||
| Changes in operating assets and liabilities: | |||
| Accrued interest receivable | |||
| Loans held for sale | |||
| Other assets | |||
| Accrued interest payable | |||
| Other liabilities | |||
| Net cash provided by operating activities | |||
| Net cash provided by operating activities | |||
| Cash flows from investing activities: | |||
| Proceeds from sales of available for sale securities | |||
| Maturities, calls, paydowns on available for sale securities | |||
| Purchases of available for sale securities | |||
| Net (increase) decrease in loans | |||
| Purchases of premises and equipment | |||
| Proceeds from redemption of FHLB stock | |||
| Purchase of FHLB stock | |||
| Proceeds from sale of equipment | |||
| Purchase of Bankers' Bank stock | |||
| Proceeds from redemption of life insurance | |||
| Purchase of life insurance | |||
| Proceeds from sale of foreclosed assets | |||
| Net cash (used) provided by investing activities | |||
| Net cash provided by (used in) investing activities | |||
| Cash flows from financing activities: | |||
| Net increase in deposits | |||
| Net (decrease) increase in escrow | |||
| Net decrease in FHLB open line of credit | |||
| Repayments of FHLB advances | |||
| Proceeds from FHLB advances | |||
| Net proceeds from issuance of common stock | |||
| Net cash provided (used) in financing activities | |||
| Repurchase of common stock | |||
| Net cash provided by financing activities | |||
| Net increase (decrease) in cash and cash equivalents | |||
| Cash and cash equivalents at beginning | |||
| Cash and cash equivalents at end | |||
| Supplemental Cash Flow Disclosures: | |||
| Cash paid for interest | |||
| Cash paid for income taxes | |||
| Loans transferred to foreclosed assets | |||
| Financed sales of foreclosed assets |
Loading...
